U
ARCA biopharma, Inc. ABIO
NASDAQ
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating U
Reward Index Unrated
Risk Index Unrated
Risk Grade U
Reward Grade U
Rating Factors ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index Unrated
Growth Index Unrated
Efficiency Index Unrated
Solvency Index Unrated
Total Return Index Unrated
Volatility Index Unrated
Beta / Standard Deviation ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.18
Price History ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return --
30-Day Total Return --
60-Day Total Return --
90-Day Total Return --
Year to Date Total Return --
1-Year Total Return --
2-Year Total Return --
3-Year Total Return --
5-Year Total Return --
52-Week High % Change --
52-Week Low % Change --
Price ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $4.49
52-Week Low Price $1.56
52-Week Low Price (Date) Jan 19, 2024
52-Week High Price (Date) May 17, 2024
Valuation ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap --
Enterprise Value --
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.50
Earnings Per Share Growth --
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 1.11
Enterprise Value/Revenue (TTM) --
Price --
Enterprise Value/EBITDA (TTM) --
Enterprise Value/EBIT --
Market Cap Category --
Dividends and Shares ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 14.51M
Dividend Yield 64.52%
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 720 940 2200
Address 10170 Church Ranch Way Westminster, CO 80021
Website www.arcabio.com
Country United States
Year Founded --
Profitability ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -14.62%
Return on Equity --
Income Statement ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -8.75M
EBIT (TTM) -8.76M
Net Income (TTM) -7.20M
Net Income Avl. to Common (TTM) -7.20M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -80.95%
EPS Diluted (TTM) -0.50
EPS Diluted Growth (Q YOY) -79.75%
Balance Sheet ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 33.28M
Cash Per Share (Q) $2.29
Total Current Assets (Q) 33.82M
Total Preferred Equity (Q) --
Total Equity (Q) 32.57M
Current Ratio (Q) 26.609
Book Value Per Share (Q) $2.25
Total Assets (Q) 33.84M
Total Current Liabilities (Q) 1.27M
Total Debt (Q) 24.00K
Total Liabilities (Q) 1.27M
Total Common Equity (Q) 32.57M
Cash Flow ABIO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 14.00K
Net Change in Cash (TTM) -6.87M
Levered Free Cash Flow (TTM) -5.08M
Cash from Operations (TTM) -6.89M
Weiss Ratings